| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0006 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |